A multicenter DeCOG study on predictors of vemurafenib therapy outcome in melanoma: pretreatment impacts survival

Ugurel, S.; Loquai, C.; Kaehler, K.; Hassel, J.; Berking, C.; Zimmer, L.; Haubitz, I.; Satzger, I.; Mueller-Brenne, T.; Mikhaimer, N. C.; Becker, J. C.; Kilian, K. J.; Schadendorf, D.; Heinzerling, L.; Kaatz, M.; Utikal, J.; Goeppner, D.; Pfoehler, C.; Pflugfelder, A.; Moessner, R.; Gutzmer, R.

dc.contributor.author	Pflugfelder, Annette Dorothee
dc.date.accessioned	2015-11-26T14:08:34Z
dc.date.available	2015-11-26T14:08:34Z
dc.date.issued	2015
dc.identifier.issn	0923-7534
dc.identifier.uri	http://hdl.handle.net/10900/66701
dc.language.iso	en	de_DE
dc.publisher	Oxford Univ Press	de_DE
dc.relation.uri	http://dx.doi.org/10.1093/annonc/mdu573	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	A multicenter DeCOG study on predictors of vemurafenib therapy outcome in melanoma: pretreatment impacts survival	de_DE
dc.type	Article	de_DE
utue.quellen.id	20150901145020_01368
utue.publikation.seiten	573-582	de_DE
utue.personen.roh	Ugurel, S.
utue.personen.roh	Loquai, C.
utue.personen.roh	Kaehler, K.
utue.personen.roh	Hassel, J.
utue.personen.roh	Berking, C.
utue.personen.roh	Zimmer, L.
utue.personen.roh	Haubitz, I.
utue.personen.roh	Satzger, I.
utue.personen.roh	Mueller-Brenne, T.
utue.personen.roh	Mikhaimer, N. C.
utue.personen.roh	Becker, J. C.
utue.personen.roh	Kilian, K. J.
utue.personen.roh	Schadendorf, D.
utue.personen.roh	Heinzerling, L.
utue.personen.roh	Kaatz, M.
utue.personen.roh	Utikal, J.
utue.personen.roh	Goeppner, D.
utue.personen.roh	Pfoehler, C.
utue.personen.roh	Pflugfelder, A.
utue.personen.roh	Moessner, R.
utue.personen.roh	Gutzmer, R.
dcterms.isPartOf.ZSTitelID	Annals of Oncology	de_DE
dcterms.isPartOf.ZS-Issue	3	de_DE
dcterms.isPartOf.ZS-Volume	26	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE